Lexaria Bioscience
LEXX
LEXX
21 hedge funds and large institutions have $1.05M invested in Lexaria Bioscience in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$335K | |
| 2 | +$70.2K | |
| 3 | +$42.5K | |
| 4 |
Renaissance Technologies
New York
|
+$5.21K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$189 |
Top Sellers
| 1 | -$400K | |
| 2 | -$29.9K | |
| 3 | -$28K | |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$5.95K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Rockefeller Capital Management
New York
| – |
|
|||
27
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – |
|